Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Farapulse Stock

farapulse.comHealthcareFounded: 1900Funding to Date: $80.75MM

FARAPULSE provides tissue-selective PFA therapy through development and commercialization of its dedicated generator (FARASTAR), PVI-focused catheter (FARAWAVE), large-area focal catheter (FARAFLEX), precision focal catheter (FARAPOINT) and a proprietary deflectable delivery sheath (FARADRIVE).

Learn more about Farapulse IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Farapulse.

Register Today

Team

Management Team

Allan Zingeler

President, Board Member & Chief Executive Officer

Board Members

James Eadie MD

Santé Ventures

Robert Weisskoff Ph.D

F-Prime Capital Partners

Andrew ElBardissi MD

Deerfield Management

Chris Kaster

Other companies like Farapulse in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Precision Neuroscience

Sector

Frequently Asked Questions